CAS 635-46-1|1,2,3,4-Tetrahydroquinoline
Introduction：Basic information about CAS 635-46-1|1,2,3,4-Tetrahydroquinoline, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | 1,2,3,4-Tetrahydroquinoline | ||
|---|---|---|---|
| CAS Number | 635-46-1 | Molecular Weight | 133.190 |
| Density | 1.0±0.1 g/cm3 | Boiling Point | 250.8±10.0 °C at 760 mmHg |
| Molecular Formula | C9H11N | Melting Point | 9-14 °C(lit.) |
| MSDS | ChineseUSA | Flash Point | 100.6±0.0 °C |
| Symbol | GHS07, GHS08 | Signal Word | Danger |
Names
| Name | 1,2,3,4-tetrahydroquinoline |
|---|---|
| Synonym | More Synonyms |
Chemical & Physical Properties
| Density | 1.0±0.1 g/cm3 |
|---|---|
| Boiling Point | 250.8±10.0 °C at 760 mmHg |
| Melting Point | 9-14 °C(lit.) |
| Molecular Formula | C9H11N |
| Molecular Weight | 133.190 |
| Flash Point | 100.6±0.0 °C |
| Exact Mass | 133.089142 |
| PSA | 12.03000 |
| LogP | 2.29 |
| Vapour Pressure | 0.0±0.5 mmHg at 25°C |
| Index of Refraction | 1.544 |
| InChIKey | LBUJPTNKIBCYBY-UHFFFAOYSA-N |
| SMILES | c1ccc2c(c1)CCCN2 |
| Storage condition | Room temperature. |
| Water Solubility | <1 g/L (20 ºC) |
Safety Information
| Symbol | GHS07, GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H315-H319-H335-H350 |
| Precautionary Statements | P201-P261-P305 + P351 + P338-P308 + P313 |
| Personal Protective Equipment | Eyeshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter |
| Hazard Codes | Xi:Irritant |
| Risk Phrases | R36/37/38 |
| Safety Phrases | S26-S36/37 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| HS Code | 29334990 |
Customs
| HS Code | 29334990 |
|---|
Articles2
More Articles| Discovery of thienoquinolone derivatives as selective and ATP non-competitive CDK5/p25 inhibitors by structure-based virtual screening. Bioorg. Med. Chem. 22(22) , 6409-21, (2014) Calpain mediated cleavage of CDK5 natural precursor p35 causes a stable complex formation of CDK5/p25, which leads to hyperphosphorylation of tau. Thus inhibition of this complex is a viable target fo... | |
| Pharmacokinetic plasma behaviors of intravenous and oral bioavailability of thymoquinone in a rabbit model. Eur. J. Drug Metab. Pharmacokinet. 40 , 319-23, (2015) Thymoquinone (THQ), the active constituent of Nigella sativa seeds, has demonstrated some potential pharmacological activities. The present study was designed to investigate the pharmacokinetic behavi... |
Synonyms
| Kusol |
| Quinoline, 1,2,3,4-tetrahydro- |
| (1H)-tetrahydroquinoline |
| MFCD00006693 |
| 2,3,4-trihydroquinoline |
| Quinoline,1,2,3,4-tetrahydro |
| 1,2,3,4-tetrahydro-quinoline |
| benzopiperidine |
| 1,3,9,9a-tetrahydroquinoline |
| tetrahydroquinoline |
| EINECS 211-237-6 |
| 1,2,3,4-Tetrahydroquinoline |
